Trademark applications and grants for Pasteur Merieux Serums Et Vaccins. Pasteur Merieux Serums Et Vaccins has 5 trademark applications. The latest application filed is for "NOVIRAB"
Patent Application | Date |
---|---|
Process for preparing a multicombinatorial library of vectors for expressing antibody genes 6,599,697 - 08/693,234 Sodoyer , et al. July 29, 2 | 2003-07-29 |
Compositions and methods for administering Borrelia DNA 6,451,769 - 09/173,053 Huebner , et al. September 17, 2 | 2002-09-17 |
Transferrin receptor subunit proteins of Neisseria meningitidis 6,326,350 - 08/867,921 Jacobs , et al. December 4, 2 | 2001-12-04 |
Malaria recombinant poxvirus vaccine 6,214,353 - 09/083,366 Paoletti , et al. April 10, 2 | 2001-04-10 |
Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug 6,124,270 - 08/750,503 Haensler September 26, 2 | 2000-09-26 |
Mark Image Registration | Serial | Trademark Application Date |
---|---|
"NOVIRAB" 75714469 |
NOVIRAB 1999-05-26 |
"VAXENOMICS" 75535597 |
VAXENOMICS 1998-08-10 |
"TYPHIM VI" 74731966 |
TYPHIM VI 1995-09-06 |
"LYMPHOGLOBULINE" 1831021 74299699 |
LYMPHOGLOBULINE 1992-07-31 |
"ACT-HIB" 1772766 74251991 |
ACT-HIB 1992-03-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.